PURI.L Share News (PURI)

PuriCore completes disposal of supermarket retail business

(ShareCast News) - Emerging specialty biopharmaceutical company PuriCore announced on Monday that the disposal of its supermarket retail business, as first indicated on 20 September, had completed. The AIM-traded firm said gross proceeds of the sale were $13.5m, subject to a final adjustment for net

PuriCore flogs off supermarket business, posts wider loss

(ShareCast News) - Specialty biopharmaceutical company PuriCore announced its interim financial results for the six months to 30 June on Tuesday - a period in which the group confirmed its strategic focus to develop novel, prescription treatments for inflammatory diseases including dermatology, opht

PuriCore secures two patents for immunomodulatory technology

(ShareCast News) - AIM-listed biopharma hopeful Puricore has been granted two US patents covering the technique for producing its 'immunomodulatory' therapy for inflammatory skin disorders. Puricore, which has developed proprietary immunomodulatory formulations that reduce the immune reaction and ca

UK Shareholder Meetings Calendar - Next 7 Days

PuriCore To Submit New Drug Application For PR022 To FDA In 2017

PuriCore To Stop Selling ProduceFresh Until Registered As Pesticide

PuriCore Appoints Christian Peters As Chief Medical Officer

DIRECTOR DEALINGS: PuriCore CEO Buys 100,000 Shares

PuriCore Considers Spin-Off Of Supermaket Retail Unit As Revenue Rises

PuriCore Appoints Balkrishan Gill To Board As Non-Executive

PuriCore Mulls Supermarket Retail Unit Sale As It Switches Focus

DIRECTOR DEALINGS: PuriCore Non-Executive Buys Shares

DIRECTOR DEALINGS: PuriCore Chairman Doubles Holding

PuriCore Loss Widens On Gross Margin Hit And Investments, But Sales Up

PuriCore Appoints Alex Martin As New Chief Executive Officer